학술논문
The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma
Document Type
Article
Author
Pan, M.; Wright, W.C.; Chapple, R.H.; Zubair, A.; Brady, S.W.; Natarajan, S.; Easton, J.; Geeleher, P.; Sandhu, M.; Batchelder, J.E.; Miller, D.; Kalathur, R.; Babu, M.M.; Blanchard, S.C.; Low, J.; Chen, T.; Huddle, B.C.; Blankenship, K.B.; Archer, P.; Stewart, E.; Gordon, B.; Dyer, M.A.; Wang, Y.; Freeman, B.B.; Posgai, M.J.; Godley, L.A.; Schuetz, J.; Chen, S.; Connelly, J.P.; Pruett-Miller, S.M.
Source
In: Nature Communications . (Nature Communications, December 2021, 12(1))
Subject
Language
English
ISSN
20411723